MorphoSys AG (MOR)
19.00
-0.34
(-1.76%)
USD |
NASDAQ |
May 17, 16:00
18.98
-0.02
(-0.11%)
After-Hours: 20:00
MorphoSys Revenue (Annual): 257.96M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 257.96M |
| December 31, 2022 | 293.46M |
| December 31, 2021 | 212.51M |
| December 31, 2020 | 374.24M |
| December 31, 2019 | 80.33M |
| December 31, 2018 | 90.26M |
| December 31, 2017 | 75.64M |
| December 31, 2016 | 55.05M |
| December 31, 2015 | 117.88M |
| December 31, 2014 | 85.08M |
| December 31, 2013 | 103.54M |
| Date | Value |
|---|---|
| December 31, 2012 | 66.75M |
| December 31, 2011 | 114.44M |
| December 31, 2010 | 115.37M |
| December 31, 2009 | 112.91M |
| December 31, 2008 | 105.16M |
| December 31, 2007 | 84.95M |
| December 31, 2006 | 66.64M |
| December 31, 2005 | 9.929M |
| December 31, 2004 | 27.34M |
| December 31, 2003 | 17.33M |
| December 31, 2002 | 15.85M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
80.33M
Minimum
2019
374.24M
Maximum
2020
243.70M
Average
257.96M
Median
2023
Revenue (Annual) Benchmarks
| Novartis AG | 46.66B |
| Immatics NV | 58.46M |
| Affimed NV | 8.959M |
| InflaRx NV | 0.0683M |
| BioNTech SE | 4.134B |